BCMA-CD19 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-CD19 CAR-T therapy, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]